Collegium Pharmaceutical Stock (NASDAQ: COLL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 487.45K |
Day Range | - - - |
52 Wk Range | 20.95 - 40.95 |
Market Cap | $1.06B |
P/E Ratio | 12.88 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 26.23% |
Days to Cover | 9.33 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Collegium Pharmaceutical (NASDAQ:COLL) through any online brokerage.
Other companies in Collegium Pharmaceutical’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS) and Phibro Animal Health (NASDAQ:PAHC).
There is no analysis for Collegium Pharmaceutical.
Collegium Pharmaceutical has a consensus price target of $36.40.
The stock price for Collegium Pharmaceutical (NASDAQ: COLL) is $32.36 last updated July 19, 2024 at 5:07 PM EDT.
There are no upcoming dividends for Collegium Pharmaceutical.
Collegium Pharmaceutical’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Collegium Pharmaceutical.
Collegium Pharmaceutical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.